Physician profile
Theodore Robert Saitz
NPI 1881937308
$2,989.61
in general payments reported to CMS, 2019-2025
22 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,677 · 2020: $132 · 2021: $17.71 · 2022: $387 · 2023: $76.59 · 2024: $584 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,617.90 | 2019 | |
| Procept Biorobotics Corporation | $377.71 | 2022-2024 | Aquabeam System |
| Coloplast Corp | $245.97 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $241.79 | 2023-2024 | Gemtesa |
| Neotract INC. | $131.82 | 2020 | |
| Verity Pharmaceuticals INC. | $51.00 | 2024 | Trelstar |
| Abbvie INC. | $48.87 | 2023-2024 | Botox |
| Intuitive Surgical, INC. | $28.54 | 2022 | |
| Urogen Pharma, INC. | $25.27 | 2024 | |
| Myovant Sciences INC. | $23.93 | 2022 | |
| Medtronic, INC. | $22.22 | 2025 | Pillcam |
| Bayer Healthcare Pharmaceuticals INC. | $21.00 | 2025 | |
| Astellas Pharma US INC | $18.59 | 2025 | Veozah |
| Endo Pharmaceuticals INC. | $17.71 | 2021 | |
| Palette Life Sciences, INC. | $17.18 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $16.77 | 2025 | |
| Cook Medical LLC | $15.98 | 2019 | |
| Acera Surgical, INC. | $15.85 | 2019 | |
| Mission Pharmacal Company | $15.02 | 2022 | |
| Laborie Medical Technologies Corp. | $13.14 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Urovant Sciences INC | $11.85 | 2022 | |
| Pfizer INC. | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Saitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.